Healthcare Pharmaceutical Biotech

Cognizil Reviews 2026: Ingredients, Pricing, Evidence & Risks

September 16, 2026 1:35 PM

Disclosure: This is commercial advertorial content and contains affiliate links. The sponsored publisher may earn a commission from qualifying purchases made through those links. See Whether This Cognizil Offer Fits Your Routine and Budget Cognizil Drops Reviews: Could This 22-Ingredient Liquid Be the Daily Memory-Support Format You've Been Looking For? (Consumer Research) Cognizil has a few things going for it that catch a shopper's eye right...

Read more

Dr. Robert Guarino Discusses Why Medical Expertise Requires Continued Learning

September 16, 2026 12:35 PM

Medical training has a clear structure. Physicians complete medical school, residency, and, in many specialties, additional fellowship training. They may earn board certification and spend years building experience in a particular area of medicine. Dr. Robert Guarino believes learning cannot end when those formal milestones are complete. Guarino is a physician with advanced training in surgical and breast pathology. His education included...

Read more

Who Accepts Insurance for Facial Feminization Surgery?

September 16, 2026 12:00 PM

Dr. Javad Sajan, a nationally recognized plastic surgeon and founder of Allure Esthetic, accepts all private insurance for facial feminization surgery, giving transgender patients a path to gender-affirming facial procedures without bearing the full cost out of pocket. With more than 1,100 Google reviews and years of experience, Dr. Sajan has been recognized as one of the best plastic surgeons by Cosmopolitan media. Facial feminization surgery,...

Read more

Medical Care Technologies Inc. (OTCID:MDCE) Receives First Human Volunteer Image Datasets for Melanoma Scan Beta Testing

September 16, 2026 9:17 AM

Medical Care Technologies Inc. (OTCID:MDCE) today announced that it has received its first human volunteer image datasets for internal testing of MDCE Melanoma Scan Beta - a concrete step beyond the Company's prior work on established public cancer imaging archives. The update follows the August 31 announcement that MDCE was seeking first volunteer cohorts for human-submitted dataset testing, and the later activation of volunteer intake. Those...

Read more

NCQA Unveils 2026 Health Plan Ratings

September 16, 2026 9:05 AM

The National Committee for Quality Assurance (NCQA) announced its 2026 Health Plan Ratings - an annual report that helps healthcare consumers and regulators assess the quality and effectiveness of health plans. Ratings evaluate commercial, Medicare Advantage (MA) and Medicaid health plans based on measures of clinical quality, patient experience and outcomes. The 2026 ratings are based primarily on 2025 performance data, with select MA measures...

Read more

Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies

September 16, 2026 9:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications including drugs in oncology and antivirals, is pleased to announce that it has advanced its lead Coronavirus drug candidate into IND-enabling studies. The Company had previously published laboratory results on its library of Anti-Coronavirus compounds in August 2024 (J. Med. Chem. 2024, 67,...

Read more

Thank You! CVS Health Celebrates Tabor Village Affordable Housing Groundbreaking in Dallas, Texas

September 16, 2026 8:45 AM

CVS Health Last month, CVS Health proudly celebrated the Groundbreaking of Tabor Village in Dallas alongside colleagues, local leaders, community organizations, and development and financing collaborators. This milestone marked the start of construction on a 229-unit mixed-income community for older adults, including 206 affordable homes for residents age 55+ earning up to 50% and 60% of Area Median Income and 23 market-rate homes. Tabor...

Read more

Cercare Medical Partners with the European Society of Neuroradiology to Support Perfusion Summit 2027

September 16, 2026 8:20 AM

Cercare Medical, a leader in advanced neuroimaging software, today announced an educational collaboration with the European Society of Neuroradiology (ESNR) in support of Perfusion Summit 2027, the company's flagship international meeting for perfusion imaging professionals. The Summit will take place 29-30 April 2027 at the Crowne Plaza Linate in Milan, Italy. Now entering its fourth year, Perfusion Summit has grown into a global meeting point...

Read more

American Medical Administrators, Inc. Appoints Mark D. Goldberg, MD, as Chief Medical Officer

September 16, 2026 8:00 AM

American Medical Administrators, Inc. (AMA) is pleased to announce the appointment of Mark D. Goldberg, MD as its new Chief Medical Officer. Dr. Goldberg brings more than 30 years of experience in primary care, physician leadership and value-based healthcare. Throughout his career, Dr. Goldberg has championed physician-led care models that improve patient outcomes while strengthening the sustainability of medical practices. He owned and operated...

Read more

WHO Identifies Resomelagon as One Of Six Dengue Drug Candidates with Evidence Supporting Further Clinical Development

September 16, 2026 5:55 AM

SynAct Pharma AB (publ) ("SynAct") (STO:SYNACT), a clinical-stage biotechnology company focused on treating inflammation through a novel therapeutic approach known as "pro-resolution", today announced that the World Health Organization (WHO) has identified resomelagon, the company's once daily oral pro-resolution therapy, as one of six dengue therapeutic candidates with evidence supporting further clinical development. In a review to guide and...

Read more

Smith & Nephew Plc Announces Result of Cash Tender Offer for 2030 Bonds

September 16, 2026 5:45 AM

Smith+Nephew, the global medical technology company (the "Company") (LSE:SN)(NYSE:SNN), announced today the results of its previously announced offer to purchase for cash (the "Tender Offer"), upon the terms and subject to the conditions set forth in an offer to purchase dated September 8, 2026 (the "Offer to Purchase"), up to U.S.$250 million aggregate principal amount (the "Maximum Tender Amount") of the Company's 2.032% Senior Notes due 2030...

Read more

iQ Biosciences and Bioz Celebrate a Longstanding Partnership Advancing Cellular Product Discovery

September 16, 2026 4:00 AM

Bioz, Inc., the scientific marketing platform that transforms peer-reviewed research into evidence-rich product experiences, is proud to celebrate its longstanding partnership with iQ Biosciences, a trusted provider of quality biospecimens, intelligent in vitro bioservices, and dependable bioconjugation solutions for drug discovery and preclinical research. For several years, iQ Biosciences has leveraged Bioz Badges across its cellular product...

Read more

TIMEFLYS Advances Global Cosmetic Active Ingredient Platform with 39 International PCT Patent Assets

September 16, 2026 2:20 AM

TIMEFLYS, a Swiss-registered patented cosmetic ingredient brand operating as a Cosmetic Active Ingredient Technology Platform, announced that its international intellectual-property portfolio has reached 39 Patent Cooperation Treaty (PCT) patent assets as of today. The company said its research and technology development is also connected with several hundred academic papers and journal publications spanning cosmetic science, active-ingredient...

Read more

BCLC and BCLC BEAUTY Expand Swiss Patent Portfolios and Scientific Cooperation

September 16, 2026 2:15 AM

BCLC, the Swiss-registered patented ingredient brand operating the Bioactive Cellular Longevity Complex platform, and BCLC BEAUTY, the patented cosmetic ingredient brand behind the Bioactive Cellular Longevity Cosmetic platform, today announced new intellectual-property and research milestones, together with an expanded framework for international scientific cooperation. As of this announcement, BCLC holds 41 international PCT patents and is...

Read more

MemoHive Reviews 2026: 5 Ingredients, No Proprietary Blend-Is This the Memo Hive Formula Buyers Have Been Waiting For?

September 15, 2026 10:45 PM

Disclaimers: This is a paid advertorial, and a commission is earned if you buy through a link in this article. Product claims are attributed to the brand, not independently endorsed. MemoHive is a dietary supplement - not a drug, not FDA-approved - and it's not intended to diagnose, treat, cure, or prevent any disease, per the brand's own disclaimer. Brand product page reviewed for this article: getmemohive.com/sear/. A separate brand press...

Read more

Quiet Tone Reviews 2026: Ingredients, Claims, Price & Guarantee

September 15, 2026 8:40 PM

Quick disclosure: this is a paid advertorial, and a commission is earned if you purchase through links in this article. Product claims are attributed to the brand, not independently endorsed. Quiet Tone is a dietary supplement - not a drug, not FDA-approved, and per the brand's own disclaimer, not intended to diagnose, treat, cure, or prevent any disease. Official site: getquiettone.com. This content is promotional and intended for consumer...

Read more

Opti Core Pro Supplement Price 2026: Could the Lower Per-Bottle Cost Make the Larger Package Worth a Closer Look?

September 15, 2026 7:40 PM

Quick disclosure before you read further: this is a paid advertorial, and a commission is earned if you purchase through links in this article. Product claims are attributed to the brand and are not independently endorsed. Opti Core Pro is marketed as a dietary supplement; dietary supplements are not FDA-approved for effectiveness before marketing the way prescription drugs are, and the brand states the product is not intended to diagnose,...

Read more

Smith & Nephew Plc Announces Pricing of Cash Tender Offer for 2030 Bonds

September 15, 2026 6:00 PM

Smith+Nephew, the global medical technology company (the "Company") (LSE:SN)(NYSE:SNN), announced today the pricing of its previously announced offer to purchase for cash (the "Tender Offer"), upon the terms and subject to the conditions set forth in an offer to purchase dated September 8, 2026 (the "Offer to Purchase"), up to U.S.$250 million aggregate principal amount (the "Maximum Tender Amount") of the Company's 2.032% Senior Notes due 2030...

Read more

Evo Slim Reviews 2026: Ingredients, Price, Safety & Guarantee

September 15, 2026 5:50 PM

A commission is earned if you purchase through the links in this article, and this content was paid for by North Supplements. Product claims are brand-attributed, not independently tested. Evo Slim is a dietary supplement; FDA does not approve dietary supplements for safety or effectiveness before marketing, and the product isn't intended to diagnose, treat, cure, or prevent any disease. Reviewed September 2026. Evo Slim Reviews: Researching...

Read more

Luna Acupuncture & Wellness Expands Support for Patients Living with Neuropathy Across Oregon

September 15, 2026 4:35 PM

Luna Acupuncture & Wellness has announced an expanded focus on support for patients living with neuropathy, making personalized acupuncture and auricular therapy services available through its clinics in Astoria and Hillsboro, Oregon. The company's approach is designed for people dealing with persistent nerve-related discomfort and the broader effects chronic symptoms can have on daily life. The announcement builds on Luna Acupuncture &...

Read more